Needham & Company LLC reissued their hold rating on shares of Aurora Cannabis (NYSE:ACB) in a research report released on Tuesday, AnalystRatings.com reports.
Other analysts have also issued reports about the stock. Pi Financial restated a neutral rating on shares of Aurora Cannabis in a report on Friday, May 15th. Jefferies Financial Group lowered shares of Aurora Cannabis from a hold rating to an underperform rating and boosted their price target for the stock from $12.00 to $14.00 in a research note on Friday, May 22nd. Desjardins upgraded shares of Aurora Cannabis to a buy rating in a research note on Friday, May 15th. Zacks Investment Research lowered shares of Aurora Cannabis from a buy rating to a hold rating in a research note on Monday, August 3rd. Finally, Eight Capital reiterated a hold rating and set a $11.00 price target on shares of Aurora Cannabis in a research note on Tuesday, May 12th. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of $16.94.
Shares of ACB opened at $6.98 on Tuesday. The firm has a market cap of $883.10 million, a P/E ratio of -0.60 and a beta of 1.59. Aurora Cannabis has a 12-month low of $5.30 and a 12-month high of $72.48. The company’s 50-day moving average price is $9.80 and its 200 day moving average price is $11.24. The company has a current ratio of 3.17, a quick ratio of 1.80 and a debt-to-equity ratio of 0.14.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Read More: Why do companies pay special dividends?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.